Structure

Physi-Chem Properties

Molecular Weight:  610.23
Volume:  623.902
LogP:  4.015
LogD:  3.661
LogS:  -4.476
# Rotatable Bonds:  13
TPSA:  146.58
# H-Bond Aceptor:  10
# H-Bond Donor:  5
# Rings:  5
# Heavy Atoms:  10

MedChem Properties

QED Drug-Likeness Score:  0.157
Synthetic Accessibility Score:  3.593
Fsp3:  0.2
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.75
MDCK Permeability:  5.3719991228717845e-06
Pgp-inhibitor:  0.469
Pgp-substrate:  0.018
Human Intestinal Absorption (HIA):  0.745
20% Bioavailability (F20%):  0.991
30% Bioavailability (F30%):  0.996

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.006
Plasma Protein Binding (PPB):  99.00801849365234%
Volume Distribution (VD):  0.627
Pgp-substrate:  0.6510718464851379%

ADMET: Metabolism

CYP1A2-inhibitor:  0.441
CYP1A2-substrate:  0.186
CYP2C19-inhibitor:  0.94
CYP2C19-substrate:  0.058
CYP2C9-inhibitor:  0.942
CYP2C9-substrate:  0.759
CYP2D6-inhibitor:  0.918
CYP2D6-substrate:  0.514
CYP3A4-inhibitor:  0.951
CYP3A4-substrate:  0.33

ADMET: Excretion

Clearance (CL):  7.93
Half-life (T1/2):  0.722

ADMET: Toxicity

hERG Blockers:  0.624
Human Hepatotoxicity (H-HT):  0.573
Drug-inuced Liver Injury (DILI):  0.384
AMES Toxicity:  0.434
Rat Oral Acute Toxicity:  0.257
Maximum Recommended Daily Dose:  0.826
Skin Sensitization:  0.556
Carcinogencity:  0.101
Eye Corrosion:  0.003
Eye Irritation:  0.006
Respiratory Toxicity:  0.009

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC179250

Natural Product ID:  NPC179250
Common Name*:   (2R,3S)-2-(3-Hydroxy-5-Methoxyphenyl)-N-[2-(4-Hydroxyphenyl)Ethyl]-6-[(Z)-3-[2-(4-Hydroxyphenyl)Ethylamino]-3-Oxoprop-1-Enyl]-2,3-Dihydro-1,4-Benzodioxine-3-Carboxamide
IUPAC Name:   (2R,3S)-2-(3-hydroxy-5-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]-6-[(Z)-3-[2-(4-hydroxyphenyl)ethylamino]-3-oxoprop-1-enyl]-2,3-dihydro-1,4-benzodioxine-3-carboxamide
Synonyms:  
Standard InCHIKey:  ABUYVRIWKJMSGL-HYKZEENLSA-N
Standard InCHI:  InChI=1S/C35H34N2O8/c1-43-29-20-25(19-28(40)21-29)33-34(35(42)37-17-15-23-4-10-27(39)11-5-23)45-31-18-24(6-12-30(31)44-33)7-13-32(41)36-16-14-22-2-8-26(38)9-3-22/h2-13,18-21,33-34,38-40H,14-17H2,1H3,(H,36,41)(H,37,42)/b13-7-/t33-,34+/m1/s1
SMILES:  COc1cc(cc(c1)O)[C@@H]1[C@@H](C(=NCCc2ccc(cc2)O)O)Oc2cc(ccc2O1)/C=CC(=NCCc1ccc(cc1)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2337121
PubChem CID:   71521887
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0002699] Benzodioxanes
        • [CHEMONTID:0002704] Phenylbenzodioxanes
          • [CHEMONTID:0002707] Phenylbenzo-1,4-dioxanes

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO17823 Lycium chinense Species Solanaceae Eukaryota fruits n.a. n.a. PMID[12467621]
NPO17823 Lycium chinense Species Solanaceae Eukaryota n.a. root n.a. PMID[16212233]
NPO17823 Lycium chinense Species Solanaceae Eukaryota root bark n.a. n.a. PMID[23282106]
NPO17823 Lycium chinense Species Solanaceae Eukaryota Root Bark n.a. n.a. PMID[26982999]
NPO17823 Lycium chinense Species Solanaceae Eukaryota fruits n.a. n.a. PMID[9090870]
NPO17823 Lycium chinense Species Solanaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO17823 Lycium chinense Species Solanaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO17823 Lycium chinense Species Solanaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO17823 Lycium chinense Species Solanaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO17823 Lycium chinense Species Solanaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 44100.0 nM PMID[559009]
NPT1 Others Radical scavenging activity IC50 = 48200.0 nM PMID[559009]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC179250 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC50380
0.9156 High Similarity NPC107602
0.9013 High Similarity NPC470935
0.9013 High Similarity NPC471032
0.8961 High Similarity NPC127402
0.8938 High Similarity NPC90984
0.8742 High Similarity NPC222039
0.8742 High Similarity NPC100478
0.8581 High Similarity NPC277857
0.8581 High Similarity NPC115144
0.8571 High Similarity NPC5462
0.8553 High Similarity NPC262189
0.8543 High Similarity NPC296898
0.8471 Intermediate Similarity NPC281549
0.8365 Intermediate Similarity NPC477612
0.8333 Intermediate Similarity NPC171932
0.8333 Intermediate Similarity NPC28440
0.8312 Intermediate Similarity NPC22317
0.8303 Intermediate Similarity NPC470936
0.8302 Intermediate Similarity NPC321657
0.8302 Intermediate Similarity NPC318373
0.8301 Intermediate Similarity NPC474390
0.8301 Intermediate Similarity NPC299583
0.8286 Intermediate Similarity NPC41122
0.8286 Intermediate Similarity NPC318805
0.8235 Intermediate Similarity NPC312770
0.8235 Intermediate Similarity NPC204848
0.8235 Intermediate Similarity NPC41473
0.8235 Intermediate Similarity NPC14600
0.8235 Intermediate Similarity NPC160607
0.8224 Intermediate Similarity NPC170694
0.8202 Intermediate Similarity NPC234318
0.8194 Intermediate Similarity NPC266197
0.8194 Intermediate Similarity NPC291101
0.8187 Intermediate Similarity NPC211561
0.8187 Intermediate Similarity NPC475250
0.8187 Intermediate Similarity NPC470826
0.8187 Intermediate Similarity NPC476969
0.8187 Intermediate Similarity NPC470098
0.8187 Intermediate Similarity NPC473266
0.8146 Intermediate Similarity NPC469625
0.8146 Intermediate Similarity NPC469613
0.8146 Intermediate Similarity NPC30043
0.8129 Intermediate Similarity NPC22517
0.8125 Intermediate Similarity NPC139699
0.8125 Intermediate Similarity NPC114659
0.8092 Intermediate Similarity NPC7903
0.8092 Intermediate Similarity NPC16208
0.8092 Intermediate Similarity NPC35932
0.8092 Intermediate Similarity NPC184447
0.8092 Intermediate Similarity NPC160991
0.8092 Intermediate Similarity NPC474134
0.8092 Intermediate Similarity NPC131128
0.809 Intermediate Similarity NPC85381
0.8086 Intermediate Similarity NPC324517
0.8086 Intermediate Similarity NPC329343
0.8086 Intermediate Similarity NPC321972
0.8079 Intermediate Similarity NPC114102
0.8079 Intermediate Similarity NPC469614
0.8079 Intermediate Similarity NPC469612
0.8065 Intermediate Similarity NPC211549
0.8063 Intermediate Similarity NPC236202
0.8063 Intermediate Similarity NPC204770
0.8063 Intermediate Similarity NPC70409
0.8063 Intermediate Similarity NPC18185
0.8063 Intermediate Similarity NPC170103
0.8063 Intermediate Similarity NPC58190
0.8063 Intermediate Similarity NPC108811
0.8063 Intermediate Similarity NPC262911
0.8063 Intermediate Similarity NPC202742
0.8063 Intermediate Similarity NPC82917
0.8063 Intermediate Similarity NPC263940
0.8063 Intermediate Similarity NPC294558
0.8052 Intermediate Similarity NPC112939
0.8052 Intermediate Similarity NPC470356
0.8052 Intermediate Similarity NPC474206
0.8052 Intermediate Similarity NPC112246
0.8052 Intermediate Similarity NPC121812
0.8052 Intermediate Similarity NPC61946
0.8052 Intermediate Similarity NPC94750
0.8046 Intermediate Similarity NPC30779
0.8037 Intermediate Similarity NPC279406
0.8037 Intermediate Similarity NPC226809
0.8026 Intermediate Similarity NPC470095
0.8026 Intermediate Similarity NPC470096
0.8026 Intermediate Similarity NPC214869
0.8026 Intermediate Similarity NPC472597
0.8025 Intermediate Similarity NPC178054
0.8025 Intermediate Similarity NPC470372
0.8013 Intermediate Similarity NPC273295
0.8013 Intermediate Similarity NPC35961
0.8013 Intermediate Similarity NPC202582
0.8013 Intermediate Similarity NPC52029
0.8013 Intermediate Similarity NPC55947
0.8013 Intermediate Similarity NPC226788
0.8013 Intermediate Similarity NPC218856
0.8013 Intermediate Similarity NPC470258
0.8013 Intermediate Similarity NPC210623
0.8013 Intermediate Similarity NPC260842
0.8013 Intermediate Similarity NPC3439
0.8013 Intermediate Similarity NPC190629
0.8013 Intermediate Similarity NPC195749
0.8013 Intermediate Similarity NPC222004
0.8013 Intermediate Similarity NPC285339
0.8012 Intermediate Similarity NPC182119
0.8012 Intermediate Similarity NPC20757
0.8012 Intermediate Similarity NPC227516
0.8 Intermediate Similarity NPC306441
0.8 Intermediate Similarity NPC96576
0.8 Intermediate Similarity NPC474639
0.8 Intermediate Similarity NPC16435
0.8 Intermediate Similarity NPC230734
0.8 Intermediate Similarity NPC227503
0.7989 Intermediate Similarity NPC286119
0.7989 Intermediate Similarity NPC195538
0.7988 Intermediate Similarity NPC224161
0.7987 Intermediate Similarity NPC310854
0.7987 Intermediate Similarity NPC66840
0.7987 Intermediate Similarity NPC470097
0.7987 Intermediate Similarity NPC256307
0.7987 Intermediate Similarity NPC471415
0.7987 Intermediate Similarity NPC114119
0.7975 Intermediate Similarity NPC469559
0.7974 Intermediate Similarity NPC201587
0.7974 Intermediate Similarity NPC253105
0.7974 Intermediate Similarity NPC470752
0.7962 Intermediate Similarity NPC472091
0.7962 Intermediate Similarity NPC472092
0.7962 Intermediate Similarity NPC472090
0.7961 Intermediate Similarity NPC472338
0.795 Intermediate Similarity NPC327412
0.795 Intermediate Similarity NPC328567
0.795 Intermediate Similarity NPC320970
0.795 Intermediate Similarity NPC320671
0.7949 Intermediate Similarity NPC102904
0.7949 Intermediate Similarity NPC176051
0.7949 Intermediate Similarity NPC103976
0.7949 Intermediate Similarity NPC474282
0.7949 Intermediate Similarity NPC326797
0.7949 Intermediate Similarity NPC107551
0.7947 Intermediate Similarity NPC155838
0.7943 Intermediate Similarity NPC251735
0.7943 Intermediate Similarity NPC285931
0.7943 Intermediate Similarity NPC328155
0.7943 Intermediate Similarity NPC181796
0.7943 Intermediate Similarity NPC271013
0.7943 Intermediate Similarity NPC8836
0.7943 Intermediate Similarity NPC217748
0.7943 Intermediate Similarity NPC54654
0.7943 Intermediate Similarity NPC290582
0.7943 Intermediate Similarity NPC7715
0.7943 Intermediate Similarity NPC279228
0.7943 Intermediate Similarity NPC104196
0.7943 Intermediate Similarity NPC42663
0.7943 Intermediate Similarity NPC222661
0.7943 Intermediate Similarity NPC239824
0.7943 Intermediate Similarity NPC15414
0.7943 Intermediate Similarity NPC49075
0.7943 Intermediate Similarity NPC182052
0.7943 Intermediate Similarity NPC258657
0.7943 Intermediate Similarity NPC229373
0.7943 Intermediate Similarity NPC311973
0.7943 Intermediate Similarity NPC90998
0.7943 Intermediate Similarity NPC290005
0.7943 Intermediate Similarity NPC476202
0.7943 Intermediate Similarity NPC185639
0.7943 Intermediate Similarity NPC223690
0.7939 Intermediate Similarity NPC46335
0.7939 Intermediate Similarity NPC157333
0.7937 Intermediate Similarity NPC274960
0.7937 Intermediate Similarity NPC143120
0.7937 Intermediate Similarity NPC473909
0.7937 Intermediate Similarity NPC181615
0.7935 Intermediate Similarity NPC260898
0.7935 Intermediate Similarity NPC151224
0.7935 Intermediate Similarity NPC234333
0.7935 Intermediate Similarity NPC47398
0.7927 Intermediate Similarity NPC187028
0.7927 Intermediate Similarity NPC18249
0.7927 Intermediate Similarity NPC10221
0.7927 Intermediate Similarity NPC140915
0.7927 Intermediate Similarity NPC197741
0.7927 Intermediate Similarity NPC305700
0.7922 Intermediate Similarity NPC11060
0.7922 Intermediate Similarity NPC168059
0.7922 Intermediate Similarity NPC263064
0.7922 Intermediate Similarity NPC229442
0.7914 Intermediate Similarity NPC474560
0.791 Intermediate Similarity NPC212237
0.791 Intermediate Similarity NPC116465
0.7908 Intermediate Similarity NPC309787
0.7908 Intermediate Similarity NPC474238
0.7898 Intermediate Similarity NPC49172
0.7898 Intermediate Similarity NPC274716
0.7898 Intermediate Similarity NPC254441
0.7898 Intermediate Similarity NPC167116
0.7895 Intermediate Similarity NPC86030
0.7895 Intermediate Similarity NPC5851
0.7888 Intermediate Similarity NPC260397
0.7888 Intermediate Similarity NPC324492

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC179250 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8313 Intermediate Similarity NPD4675 Approved
0.8313 Intermediate Similarity NPD4678 Approved
0.8121 Intermediate Similarity NPD7975 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD4123 Phase 3
0.7943 Intermediate Similarity NPD8053 Approved
0.7943 Intermediate Similarity NPD8054 Approved
0.7831 Intermediate Similarity NPD5773 Approved
0.7831 Intermediate Similarity NPD5772 Approved
0.7805 Intermediate Similarity NPD4005 Discontinued
0.7778 Intermediate Similarity NPD7447 Phase 1
0.7778 Intermediate Similarity NPD3027 Phase 3
0.7771 Intermediate Similarity NPD7945 Clinical (unspecified phase)
0.775 Intermediate Similarity NPD6331 Phase 2
0.775 Intermediate Similarity NPD6658 Clinical (unspecified phase)
0.7742 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7742 Intermediate Similarity NPD1613 Approved
0.7716 Intermediate Similarity NPD7212 Phase 2
0.7716 Intermediate Similarity NPD7213 Phase 3
0.7701 Intermediate Similarity NPD8156 Discontinued
0.7683 Intermediate Similarity NPD2122 Discontinued
0.7644 Intermediate Similarity NPD8251 Approved
0.7644 Intermediate Similarity NPD8252 Approved
0.7644 Intermediate Similarity NPD8099 Discontinued
0.7628 Intermediate Similarity NPD5837 Clinical (unspecified phase)
0.7622 Intermediate Similarity NPD5261 Clinical (unspecified phase)
0.7597 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7564 Intermediate Similarity NPD2674 Phase 3
0.7532 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7516 Intermediate Similarity NPD7153 Discontinued
0.7515 Intermediate Similarity NPD7526 Approved
0.7515 Intermediate Similarity NPD52 Approved
0.7515 Intermediate Similarity NPD6818 Clinical (unspecified phase)
0.7515 Intermediate Similarity NPD7527 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD2161 Phase 2
0.7485 Intermediate Similarity NPD2219 Phase 1
0.7484 Intermediate Similarity NPD4908 Phase 1
0.743 Intermediate Similarity NPD7549 Discontinued
0.7405 Intermediate Similarity NPD1558 Phase 1
0.7396 Intermediate Similarity NPD6072 Discontinued
0.7394 Intermediate Similarity NPD4357 Discontinued
0.7389 Intermediate Similarity NPD3144 Approved
0.7389 Intermediate Similarity NPD3145 Approved
0.7389 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7378 Intermediate Similarity NPD5307 Clinical (unspecified phase)
0.7372 Intermediate Similarity NPD5752 Clinical (unspecified phase)
0.7362 Intermediate Similarity NPD3060 Approved
0.7346 Intermediate Similarity NPD1375 Discontinued
0.7342 Intermediate Similarity NPD7477 Discontinued
0.7333 Intermediate Similarity NPD7124 Phase 2
0.733 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.733 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.733 Intermediate Similarity NPD6166 Phase 2
0.7326 Intermediate Similarity NPD7773 Phase 2
0.7322 Intermediate Similarity NPD7906 Approved
0.731 Intermediate Similarity NPD7046 Clinical (unspecified phase)
0.731 Intermediate Similarity NPD7089 Clinical (unspecified phase)
0.7294 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7283 Intermediate Similarity NPD4055 Discovery
0.7256 Intermediate Similarity NPD4162 Approved
0.7256 Intermediate Similarity NPD5177 Phase 3
0.7251 Intermediate Similarity NPD5722 Discontinued
0.7244 Intermediate Similarity NPD6584 Phase 3
0.7225 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7216 Intermediate Similarity NPD4606 Clinical (unspecified phase)
0.72 Intermediate Similarity NPD6746 Phase 2
0.7184 Intermediate Similarity NPD7831 Phase 2
0.7184 Intermediate Similarity NPD7832 Clinical (unspecified phase)
0.7184 Intermediate Similarity NPD7833 Phase 2
0.7176 Intermediate Similarity NPD8158 Clinical (unspecified phase)
0.7176 Intermediate Similarity NPD7261 Clinical (unspecified phase)
0.717 Intermediate Similarity NPD5718 Phase 2
0.7152 Intermediate Similarity NPD4236 Phase 3
0.7152 Intermediate Similarity NPD4237 Approved
0.7151 Intermediate Similarity NPD1934 Approved
0.7143 Intermediate Similarity NPD4160 Clinical (unspecified phase)
0.7135 Intermediate Similarity NPD6841 Approved
0.7135 Intermediate Similarity NPD6843 Phase 3
0.7135 Intermediate Similarity NPD6842 Approved
0.7134 Intermediate Similarity NPD2029 Clinical (unspecified phase)
0.7127 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7126 Intermediate Similarity NPD6788 Approved
0.7125 Intermediate Similarity NPD1726 Clinical (unspecified phase)
0.7118 Intermediate Similarity NPD3687 Approved
0.7118 Intermediate Similarity NPD3686 Approved
0.7117 Intermediate Similarity NPD6028 Clinical (unspecified phase)
0.7117 Intermediate Similarity NPD6029 Clinical (unspecified phase)
0.7115 Intermediate Similarity NPD2922 Phase 1
0.7111 Intermediate Similarity NPD7054 Approved
0.7108 Intermediate Similarity NPD7466 Approved
0.7104 Intermediate Similarity NPD7310 Approved
0.7104 Intermediate Similarity NPD7313 Approved
0.7104 Intermediate Similarity NPD7311 Approved
0.7104 Intermediate Similarity NPD7312 Approved
0.7099 Intermediate Similarity NPD1772 Clinical (unspecified phase)
0.7091 Intermediate Similarity NPD7596 Clinical (unspecified phase)
0.7086 Intermediate Similarity NPD8070 Approved
0.7086 Intermediate Similarity NPD5604 Discontinued
0.7072 Intermediate Similarity NPD7472 Approved
0.7072 Intermediate Similarity NPD7074 Phase 3
0.7066 Intermediate Similarity NPD5241 Discontinued
0.7065 Intermediate Similarity NPD7309 Approved
0.7055 Intermediate Similarity NPD6111 Discontinued
0.7051 Intermediate Similarity NPD2982 Phase 2
0.7051 Intermediate Similarity NPD2983 Phase 2
0.7051 Intermediate Similarity NPD6583 Phase 3
0.7051 Intermediate Similarity NPD3676 Clinical (unspecified phase)
0.7051 Intermediate Similarity NPD6582 Phase 2
0.7049 Intermediate Similarity NPD8453 Clinical (unspecified phase)
0.7049 Intermediate Similarity NPD7808 Phase 3
0.7043 Intermediate Similarity NPD7243 Clinical (unspecified phase)
0.7041 Intermediate Similarity NPD4739 Approved
0.7033 Intermediate Similarity NPD7007 Discovery
0.7033 Intermediate Similarity NPD6996 Clinical (unspecified phase)
0.7032 Intermediate Similarity NPD1610 Phase 2
0.7022 Intermediate Similarity NPD3051 Approved
0.7022 Intermediate Similarity NPD6071 Discontinued
0.7019 Intermediate Similarity NPD840 Approved
0.7019 Intermediate Similarity NPD839 Approved
0.7018 Intermediate Similarity NPD1653 Approved
0.7011 Intermediate Similarity NPD4577 Approved
0.7011 Intermediate Similarity NPD2978 Approved
0.7011 Intermediate Similarity NPD4578 Approved
0.7011 Intermediate Similarity NPD2977 Approved
0.7011 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD5677 Discontinued
0.7006 Intermediate Similarity NPD7201 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD3489 Phase 3
0.6994 Remote Similarity NPD3778 Approved
0.6993 Remote Similarity NPD1548 Phase 1
0.6989 Remote Similarity NPD4663 Approved
0.6987 Remote Similarity NPD2981 Phase 2
0.6983 Remote Similarity NPD2969 Approved
0.6983 Remote Similarity NPD2970 Approved
0.6981 Remote Similarity NPD3018 Phase 2
0.6973 Remote Similarity NPD7090 Clinical (unspecified phase)
0.6961 Remote Similarity NPD7493 Clinical (unspecified phase)
0.6961 Remote Similarity NPD7228 Approved
0.6959 Remote Similarity NPD7590 Clinical (unspecified phase)
0.6944 Remote Similarity NPD2489 Approved
0.6944 Remote Similarity NPD27 Approved
0.6943 Remote Similarity NPD1669 Approved
0.6928 Remote Similarity NPD3656 Approved
0.6928 Remote Similarity NPD7266 Discontinued
0.6923 Remote Similarity NPD6783 Clinical (unspecified phase)
0.6919 Remote Similarity NPD8151 Discontinued
0.6914 Remote Similarity NPD2801 Approved
0.6909 Remote Similarity NPD4108 Discontinued
0.6902 Remote Similarity NPD7039 Approved
0.6902 Remote Similarity NPD7251 Discontinued
0.6902 Remote Similarity NPD7038 Approved
0.6901 Remote Similarity NPD1350 Approved
0.6901 Remote Similarity NPD1351 Approved
0.6901 Remote Similarity NPD1349 Approved
0.6899 Remote Similarity NPD7258 Clinical (unspecified phase)
0.6897 Remote Similarity NPD5089 Approved
0.6897 Remote Similarity NPD5090 Approved
0.6895 Remote Similarity NPD7125 Discontinued
0.6893 Remote Similarity NPD6971 Discontinued
0.6891 Remote Similarity NPD8095 Phase 1
0.6891 Remote Similarity NPD7237 Clinical (unspecified phase)
0.689 Remote Similarity NPD3054 Approved
0.689 Remote Similarity NPD3052 Approved
0.689 Remote Similarity NPD5314 Approved
0.6886 Remote Similarity NPD7037 Approved
0.6882 Remote Similarity NPD1774 Approved
0.6879 Remote Similarity NPD2235 Phase 2
0.6879 Remote Similarity NPD2231 Phase 2
0.6875 Remote Similarity NPD2861 Phase 2
0.6875 Remote Similarity NPD2560 Approved
0.6875 Remote Similarity NPD2563 Approved
0.6871 Remote Similarity NPD2238 Phase 2
0.6864 Remote Similarity NPD2677 Approved
0.6864 Remote Similarity NPD3692 Discontinued
0.6854 Remote Similarity NPD6234 Discontinued
0.6852 Remote Similarity NPD6812 Clinical (unspecified phase)
0.6852 Remote Similarity NPD5109 Approved
0.6852 Remote Similarity NPD5110 Phase 2
0.6852 Remote Similarity NPD5111 Phase 2
0.6848 Remote Similarity NPD6797 Phase 2
0.6848 Remote Similarity NPD6895 Approved
0.6848 Remote Similarity NPD6896 Approved
0.6845 Remote Similarity NPD6674 Discontinued
0.6842 Remote Similarity NPD3985 Discontinued
0.6842 Remote Similarity NPD7446 Clinical (unspecified phase)
0.6842 Remote Similarity NPD1754 Clinical (unspecified phase)
0.6842 Remote Similarity NPD3536 Discontinued
0.6839 Remote Similarity NPD6502 Phase 2
0.6831 Remote Similarity NPD5844 Phase 1
0.6818 Remote Similarity NPD8455 Phase 2
0.681 Remote Similarity NPD3530 Approved
0.681 Remote Similarity NPD3531 Approved
0.681 Remote Similarity NPD3532 Approved
0.679 Remote Similarity NPD4625 Phase 3
0.6788 Remote Similarity NPD2157 Approved
0.6788 Remote Similarity NPD2568 Approved
0.6782 Remote Similarity NPD6523 Clinical (unspecified phase)
0.678 Remote Similarity NPD3817 Phase 2
0.678 Remote Similarity NPD6063 Approved
0.678 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6778 Remote Similarity NPD7199 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data